Market Overview

According to the research report, the plasma powder market was valued at USD 2.95 billion in 2022 and is expected to reach USD 4.69 billion by 2032, to grow at a CAGR of 4.8% during the forecast period.

Plasma powder is a dry form of blood plasma typically derived from porcine, bovine, or poultry sources. The plasma is spray-dried to produce a high-protein, shelf-stable powder rich in albumin, globulins, and other bioactive compounds. It is widely utilized in:

• Animal feed formulations (particularly for weanling pigs, calves, poultry, and aquaculture)
• Pharmaceuticals and nutraceuticals
• Food industry applications such as emulsifiers and stabilizers

Due to its high digestibility, immune-boosting capabilities, and functional versatility, plasma powder is becoming a preferred ingredient across industries aiming to improve nutritional value and product performance.

Key Market Growth Drivers

1. Expanding Animal Feed Industry

One of the primary drivers of the plasma powder market is the burgeoning animal feed industry. Plasma powder is recognized for its superior digestibility and immunoglobulin content, making it highly effective for promoting gut health and improving growth rates in livestock—particularly young pigs and poultry.

As global meat consumption continues to rise, livestock producers are under pressure to improve feed efficiency and animal welfare. Plasma powder helps reduce the use of antibiotics by enhancing the animals' natural immunity, making it an attractive solution in the era of antibiotic-free meat production.

2. Growing Demand for Functional Proteins

The increasing global focus on health and wellness has fueled demand for functional proteins, not only in animal nutrition but also in human dietary supplements. Plasma powder offers excellent bioavailability and supports immune system modulation, making it valuable in clinical nutrition, elderly care, and functional food products.

Additionally, innovations in processing technologies have improved the sensory properties and stability of plasma powders, facilitating their incorporation into various health and nutritional products.

3. Rise in Sustainable Protein Sources

Sustainability concerns are driving the shift toward alternative protein sources. Plasma powder production makes use of blood, a by-product of the meat industry, that would otherwise be discarded. This contributes to the circular economy and reduces environmental impact, making plasma powder a sustainable protein alternative with low carbon footprint.

Governments and sustainability-focused organizations are promoting resource-efficient production practices, and plasma powder aligns with these goals by minimizing waste and maximizing nutritional output.

4. Growth in Plasma-Derived Ingredients in Pharmaceuticals

Blood plasma proteins are widely recognized for their therapeutic value in human medicine. Albumin, fibrinogen, and immunoglobulins extracted from plasma powder are being researched for potential applications in wound healing, immune support, and chronic disease management.

The growing interest in biopharmaceuticals, coupled with an aging population and rising prevalence of immune-related disorders, is creating new opportunities for plasma powder in pharmaceutical formulations.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/plasma-powder-market

Market Challenges

1. Ethical and Regulatory Concerns

Despite its nutritional benefits, plasma powder faces ethical scrutiny, especially in regions with strict food safety and animal welfare standards. In some markets, the use of animal-derived proteins in human food products may face resistance from consumers or regulatory bodies.

Moreover, regulations governing the sourcing, processing, and labeling of plasma-derived ingredients vary by country, leading to complexity and compliance challenges for manufacturers.

2. Disease Transmission and Biosecurity Risks

The use of animal blood in feed raises concerns about the potential transmission of pathogens such as BSE (mad cow disease) or swine fever. Although modern processing techniques ensure biosecurity through heat treatment and filtration, outbreaks in livestock populations can lead to temporary bans or restrictions, disrupting supply chains.

Ensuring traceability, quality control, and adherence to biosecurity protocols is critical for maintaining market trust and minimizing health risks.

3. Consumer Perception and Religious Restrictions

Consumer aversion to blood-based products and religious dietary restrictions (such as halal or kosher requirements) can limit the adoption of plasma powder in certain food and supplement markets. Educating end users about the safety, sustainability, and nutritional value of these ingredients remains a challenge.

4. Competition from Plant-Based Proteins

The rapid growth of plant-based protein alternatives has introduced competition in the functional protein market. While plasma powder offers superior bioavailability, the rising demand for vegan and allergen-free products could divert attention and investment away from animal-derived ingredients.

Regional Analysis

North America

North America holds a dominant share of the plasma powder market, accounting for nearly 35% of global revenue in 2024. The United States leads in both production and consumption, driven by the well-established animal feed industry, advanced food processing infrastructure, and growing investment in plasma-derived pharmaceutical products.

The region also benefits from strong regulatory oversight and established protocols for biosafety and quality assurance in animal protein processing.

Europe

Europe follows closely, with key markets in Germany, France, and the Netherlands contributing significantly. Stringent EU regulations around animal by-product use have led to the development of high-quality plasma powders with transparent sourcing. The region’s focus on sustainable agriculture and ethical food sourcing supports moderate growth in the plasma-derived ingredient sector.

Asia-Pacific

Asia-Pacific is the fastest-growing regional market, projected to grow at a CAGR of over 9% during the forecast period. With rising meat consumption, growing livestock populations, and expanding aquaculture industries, countries like China, India, and Vietnam are increasingly incorporating plasma powder in feed formulations.

Additionally, increasing health awareness and rising disposable incomes are boosting demand for functional proteins in human nutrition across the region.

Latin America

Latin America, particularly Brazil and Argentina, is emerging as a key production hub due to the presence of large-scale slaughterhouses and livestock processing facilities. Export opportunities for plasma powder from this region are increasing, especially to North America and Europe.

Middle East & Africa

Although still a nascent market, the Middle East & Africa region is witnessing gradual adoption of advanced animal nutrition practices. As food security and local production capabilities improve, the use of plasma powder is expected to rise in both feed and food sectors.

Key Companies in the Plasma Powder Market

The global plasma powder market is moderately consolidated, with a mix of multinational players and regional specialists. Key companies include:

1. Darling Ingredients Inc.

A global leader in sustainable protein ingredients, Darling Ingredients offers a wide range of animal by-products, including plasma powders for both feed and human health applications.

2. Sera Scandia A/S

Based in Denmark, Sera Scandia is known for high-quality spray-dried plasma products designed for piglet feed, aquaculture, and pet nutrition.

3. Lican Food

A major Chilean company involved in the production and export of blood plasma proteins and other meat co-products for global feed and food markets.

4. Sonac (Part of Darling Ingredients)

Sonac operates globally and offers a diverse portfolio of animal proteins and fats, including functional plasma-derived ingredients for feed, pet food, and food applications.

5. Kraeber & Co GmbH

Specializes in biotechnologically derived proteins for pharmaceutical and clinical use, including plasma-based proteins for therapeutic development.

6. APC, Inc.

One of the pioneers in commercializing spray-dried plasma for animal feed, APC is a key player in North America, with extensive R&D in animal nutrition and gut health.

Other noteworthy players include Biovet S.A., Lihme Protein Solutions, Lauridsen Group, and Bioiberica S.A.U.

Future Outlook

The future of the plasma powder market looks promising as it aligns with major global trends—sustainability, nutritional enhancement, and animal welfare. As research continues to uncover new health applications for blood plasma proteins, opportunities in human nutrition and pharmaceuticals will expand.

However, companies must navigate regulatory frameworks, invest in biosecurity, and develop educational campaigns to address consumer concerns and unlock new growth potential.

Conclusion

The Plasma Powder Market is evolving rapidly, backed by the growing use of functional proteins in the animal feed industry and beyond. As the world seeks efficient, sustainable, and health-oriented protein solutions, plasma-derived ingredients are poised to play a crucial role. With innovation and responsible sourcing at its core, the plasma powder industry is entering a transformative phase that bridges nutrition, sustainability, and scientific advancement.

More Trending Latest Reports By Polaris Market Research:

Data Center Market

Countertops Market

Hair Styling Products Market

In-App Purchase Market

Video Analytics Market

Top AI In Genomics Companies: Accelerating Discoveries in Genomics Research

Property Management Market

India Diagnostic Services Market

White Noise Machine Market